Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.

Tools

Item Type:	Letter
Title:	Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.
Creators:	Wais, V., Kündgen, L., Bohl, S.R., von Harsdorf, S., Schlenk, R.F., Döhner, K., Teleanu, V., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Nguyen, T.M., Drognitz, K., Moulin, J.C., Binnenhei, M., Bentz, M., Döhner, H., Bunjes, D., Kuchenbauer, F. and Ringhoffer, M.
Keywords:	Acute Myeloid Leukaemia, Chemotherapy, Risk Factors, Stem-Cell Therapies
Source:	Bone Marrow Transplantation
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Volume:	53
Number:	1
Page Range:	94-96
Date:	January 2018
Official Publication:	https://doi.org/10.1038/bmt.2017.211
PubMed:	View item in PubMed

Repository Staff Only: item control page